A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.
Epistemonikos ID: aa6a196207fe00a428552d0ebf40bef0e24fcb47
First added on: May 08, 2024